Artal Group S.A. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $39.5 Million - $55.6 Million	-400,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $26.3 Million - $42 Million	400,000 New	400,000 $38.8 Million
Q4 2017 Feb 09, 2018	SELL	$20.44 - $35.56 $1.02 Million - $1.78 Million	-50,000 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$23.54 - $38.21 $1.18 Million - $1.91 Million	50,000	50,000 $1.87 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.